📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. (2020)

First Author: Wang Y

Attributed to: COVID-19: multi-arm, multi stage adaptive clinical trial (CoV-MAMS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)31022-9

PubMed Identifier: 32423584

Publication URI: http://europepmc.org/abstract/MED/32423584

Type: Journal Article/Review

Volume: 395

Parent Publication: Lancet (London, England)

Issue: 10236

ISSN: 0140-6736